When testing AD genetic risk variants, we found enrichment for ABCA7, PICALM, IL-34 and CLNK. While ABCA7 and IL-34 are expressed in the choroid plexus73,74, PICALM is expressed in the blood–brain barrier75. This evidence concerns the gene CLNK and Alzheimer disease.